ISBN: 9789401797313 - kinesins and cancer (9 résultats)

Affiner la recherche

  • Livres (9)

à

Fourchette de prix personnalisée (EUR)

à

  • Langue : anglais

    Edité par Springer, 2015

    9401797315 / 9789401797313

    • Couverture rigide

    Vendeur : Ria Christie Collections, Uxbridge, Royaume-UniRia Christie Collections

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 131,20

    EUR 13,48 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : New. In English.

  • Langue : anglais

    Edité par Springer, 2015

    9401797315 / 9789401797313

    • Couverture rigide

    Vendeur : AHA-BUCH GmbH, Einbeck, AllemagneAHA-BUCH GmbH

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 124,85

    EUR 35,00 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 1 disponible

    Buch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - This interdisciplinary volume collates research work on kinesins and cancer. Authors attempt to validate members of the kinesin superfamily as potential targets for drug development in cancer chemotherapy. The work begins by highlighting the importance of kinesins, summarising current knowledge and how they are shown to be crucial for mitosis. Chapters go on to explore how this family of proteins are emerging as a novel target for chemotherapeutic intervention and drug development.Readers will learn how kinesins travel along microtubules to fulfill their many roles in intracellular transport or cell division. Several compounds that inhibit two mitotic kinesins (called Eg5 and CENP-E) have entered Phase I and II clinical trials and are explored in these chapters. Additional mitotic kinesins are currently being validated as drug targets, raising the possibility that the repertoire of kinesin-based drug targets may expand in the future.The book is suitable as a reference standard for the field of kinesins and cancer. It will interest those in academia and pharmaceutical companies, and anyone with an interest in the medical relevance of these proteins, which cutting edge methodologies are now enabling us to understand in astonishing detail.…

  • Langue : anglais

    Edité par Springer, 2015

    9401797315 / 9789401797313

    • Couverture rigide

    Vendeur : Revaluation Books, Exeter, Royaume-UniRevaluation Books

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 160,58

    EUR 14,93 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : 2 disponibles

    Hardcover. Etat : Brand New. 1st edition. 271 pages. 9.25x6.25x0.75 inches. In Stock.

  • Langue : anglais

    Edité par Springer Netherlands, 2015

    9401797315 / 9789401797313

    • Couverture rigide

    Vendeur : Buchpark, Trebbin, AllemagneBuchpark

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Occasion - Très bon

    EUR 83,65

    EUR 105,00 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 1 disponible

    Etat : Sehr gut. Zustand: Sehr gut | Seiten: 284 | Sprache: Englisch | Produktart: Bücher | This interdisciplinary volume collates research work on kinesins and cancer. Authors attempt to validate members of the kinesin superfamily as potential targets for drug development in cancer chemotherapy. The work begins by highlighting the importance of kinesins, summarising current knowledge and how they are shown to be crucial for mitosis. Chapters go on to explore how this family of proteins are emerging as a novel target for chemotherapeutic intervention and drug development.Readers will learn how kinesins travel along microtubules to fulfill their many roles in intracellular transport or cell division. Several compounds that inhibit two mitotic kinesins (called Eg5 and CENP-E) have entered Phase I and II clinical trials and are explored in these chapters. Additional mitotic kinesins are currently being validated as drug targets, raising the possibility that the repertoire of kinesin-based drug targets may expand in the future.The book is suitable as a reference standard for the field of kinesins and cancer. It will interest those in academia and pharmaceutical companies, and anyone with an interest in the medical relevance of these proteins, which cutting edge methodologies are now enabling us to understand in astonishing detail. …

  • Langue : anglais

    Edité par Springer, 2015

    9401797315 / 9789401797313

    • Couverture rigide

    Vendeur : Mispah books, Redhill, SURRE, Royaume-UniMispah books

    Vendeur avec une évaluation de 4 étoiles
    Contacter le vendeur

    Etat: Occasion - Comme neuf

    EUR 209,12

    EUR 29,86 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : 1 disponible

    Hardcover. Etat : Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

  • Langue : anglais

    Edité par Springer, 2015

    9401797315 / 9789401797313

    • Couverture rigide
    • impression à la demande

    Vendeur : Brook Bookstore On Demand, Napoli, NA, ItalieBrook Bookstore On Demand

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 86,24

    EUR 6,80 expédition 
    Expédition depuis Italie vers Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : new. Questo è un articolo print on demand.

  • Langue : anglais

    Edité par Springer Netherlands Mrz 2015, 2015

    9401797315 / 9789401797313

    • Couverture rigide
    • impression à la demande

    Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, AllemagneBuchWeltWeit Ludwig Meier e.K.

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 106,99

    EUR 23,00 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 2 disponibles

    Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This interdisciplinary volume collates research work on kinesins and cancer. Authors attempt to validate members of the kinesin superfamily as potential targets for drug development in cancer chemotherapy. The work begins by highlighting the importance of kinesins, summarising current knowledge and how they are shown to be crucial for mitosis. Chapters go on to explore how this family of proteins are emerging as a novel target for chemotherapeutic intervention and drug development.Readers will learn how kinesins travel along microtubules to fulfill their many roles in intracellular transport or cell division. Several compounds that inhibit two mitotic kinesins (called Eg5 and CENP-E) have entered Phase I and II clinical trials and are explored in these chapters. Additional mitotic kinesins are currently being validated as drug targets, raising the possibility that the repertoire of kinesin-based drug targets may expand in the future.The book is suitable as a reference standard for the field of kinesins and cancer. It will interest those in academia and pharmaceutical companies, and anyone with an interest in the medical relevance of these proteins, which cutting edge methodologies are now enabling us to understand in astonishing detail. 284 pp. Englisch.…

  • Langue : anglais

    Edité par Springer Netherlands, 2015

    9401797315 / 9789401797313

    • Couverture rigide
    • impression à la demande

    Vendeur : moluna, Greven, Allemagnemoluna

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 92,27

    EUR 48,99 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Gebunden. Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Covers the entire, interdisciplinary field of kinesins and cancer through expert contributionsOffers a timely reference standard on the relevance of kinesins to cancer treatmentContributes to potential initial validation of mitotic ki.…

  • Langue : anglais

    Edité par Springer, Springer Mär 2015, 2015

    9401797315 / 9789401797313

    • Couverture rigide
    • impression à la demande

    Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagnebuchversandmimpf2000

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 106,99

    EUR 60,00 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 1 disponible

    Buch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -This interdisciplinary volume collates research work on kinesins and cancer. Authors attempt to validate members of the kinesin superfamily as potential targets for drug development in cancer chemotherapy. The work begins by highlighting the importance of kinesins, summarising current knowledge and how they are shown to be crucial for mitosis. Chapters go on to explore how this family of proteins are emerging as a novel target for chemotherapeutic intervention and drug development.Readers will learn how kinesins travel along microtubules to fulfill their many roles in intracellular transport or cell division. Several compounds that inhibit two mitotic kinesins (called Eg5 and CENP-E) have entered Phase I and II clinical trials and are explored in these chapters. Additional mitotic kinesins are currently being validated as drug targets, raising the possibility that the repertoire of kinesin-based drug targets may expand in the future.The book is suitable as a reference standard for the field of kinesins and cancer. It will interest those in academia and pharmaceutical companies, and anyone with an interest in the medical relevance of these proteins, which cutting edge methodologies are now enabling us to understand in astonishing detail.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 284 pp. Englisch.…